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Critical Reviews in Oral Biology & Medicine
Introduction
Tobacco smoking is a major risk factor for oral diseases such 
as oral cancer and periodontitis (US Surgeon General 2014). 
Dental professionals have an important role to play in provid-
ing smoking cessation advice and support to their patients who 
smoke and in considering this risk factor when planning and 
providing dental treatment. Nicotine is the main psychoactive, 
chemically addictive component in tobacco smoke. Yet, it is 
now widely accepted that nicotine is not responsible for the 
general health harms that result from smoking (National 
Institute for Health and Care Excellence 2013; Stratton et al. 
2018). Nicotine has been used therapeutically as a smoking 
cessation aid for over 3 decades in the form of nicotine replace-
ment therapies (NRTs), and high-quality evidence supports 
NRT effectiveness.
Between 2006 and 2009, a new category of nicotine prod-
ucts started to emerge, electronic cigarettes or e-cigarettes. 
There are now over 40 million users of e-cigarettes worldwide, 
and in 2019, the industry was estimated to be worth over 
US$19.3 billion per annum (British Broadcasting Corporation 
2019). E-cigarettes generally contain 3 main categories of 
ingredients: a carrier solution (propylene glycol and/or vegeta-
ble glycerin), nicotine (although some e-cigarettes are nicotine 
free), and flavorings. E-cigarettes have proved to be controver-
sial, and their potential risks and benefits have been exten-
sively debated in many health and social care disciplines. From 
a smoking cessation perspective, there is clinical trial evidence 
that they are an effective tobacco cessation aid when used in a 
specialist environment (Liu et al. 2018; Hartmann-Boyce et al. 
2020), but large population-based studies have presented con-
flicting conclusions (Beard et al. 2020; Pierce et al. 2020). To 
date, many of the clinical trials have been conducted on spe-
cific populations (e.g., dependent smokers, with high rates of 
social disadvantages, and motivated to quit) and in specialist 
environments with expert support. It is likely that the effective-
ness of e-cigarettes demonstrated in these trials will not be rep-
licated in “real-world” settings, and it is important that future 
trials evaluate this. The regulation of e-cigarettes varies around 
the world, but in the United States, e-cigarettes have yet to 
receive US Food and Drug Administration (FDA) approval as 
quit aids (Lavacchi et al. 2020). It is important for dental pro-
fessionals to understand if e-cigarettes are an effective smok-
ing cessation aid as this will have substantial impacts on oral 
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Abstract
Novel nicotine products, particularly electronic cigarettes (e-cigarettes), have become increasingly popular over the past decade. 
E-cigarettes are sometimes regarded as a less harmful alternative to tobacco smoking, and there is some evidence of their potential role 
as a smoking cessation aid. However, there are concerns about their health consequences, particularly in users who are not tobacco 
smokers, and also when used long term. Given the mode of delivery of these products, there is potential for oral health consequences. 
Over the past few years, there have been an increasing number of studies conducted to explore their oral health effects. In vitro studies 
have reported a range of cellular effects, but these are much less pronounced than those resulting from exposure to tobacco smoke. 
Microbiological studies have indicated that e-cigarette users have a distinct microbiome, and there is some indication this may be more 
pathogenic compared to nonusers. Evidence of oral health effects from clinical trials is still limited, and most studies to date have been 
small in scale and usually cross-sectional in design. Epidemiological studies highlight concerns over oral dryness, irritation, and gingival 
diseases. Interpreting data from e-cigarette studies is challenging, given the different populations that have been investigated and the 
continual emergence of new products. Overall, studies reveal potential oral health harms, underscoring the importance of efforts to 
reduce use in nonsmokers. However, in smokers who are using e-cigarettes as an aid to help them quit, the benefits of quitting tobacco 
smoking may outweigh any negative oral health impacts of e-cigarette use, particularly in the short term. Future research is needed to 
understand the clinical significance of some of the biological changes observed by following different cohorts of users longitudinally in 
carefully designed clinical studies and pragmatic trials supported by high-quality in vitro studies.
Keywords: electronic nicotine delivery systems, tobacco, dental research, periodontal diseases, nicotine, oral health
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health. However, it is also important to understand the stand-
alone risks that e-cigarette use may present. The Table sum-
marizes some of the potential merits and disadvantages of 
e-cigarettes.
Tobacco smoking is responsible for considerable morbidity 
and mortality, with half of all smokers dying from a smoking-
related disease such as cancer, respiratory disease, or vascular 
disease (Doll et al. 2004). The systemic health effects of 
e-cigarettes are still under investigation and the subject of 
some debate. It is widely accepted that e-cigarettes emit fewer 
toxicants than tobacco smoking (US Surgeon General 2014). A 
recent systematic review (Hartmann-Boyce et al. 2020), which 
included studies with a maximum 2-y follow-up, did not iden-
tify evidence of harmful effects caused by nicotine-containing 
e-cigarettes. Several other reviews have identified possible 
cardiovascular and respiratory harms (Gotts et al. 2019; 
Buchanan et al. 2020; Miyashita et al. 2020). Particular con-
cerns have been raised about potential harms on the developing 
adolescent brain that require more investigation (US Surgeon 
General 2014).
The possible oral health effects of e-cigarettes have been 
vigorously debated in the dental literature over recent years. In 
this article, we review the evidence in 4 main areas: 1) basic 
science studies that evaluated cell lines and tissue cultures, 2) 
microbiological evidence from basic science and clinical 
research, 3) evidence from clinical studies evaluating oral 
health and smoking cessation (in dental settings), and 4) evi-
dence from epidemiological studies. The topic of e-cigarettes 
can be emotive, which can create the risk of lack of equipoise 
in research studies. Likewise, the field has been subject to “hot 
stuff bias,” which refers to the concept that when a topic is new 
or fashionable, investigators may be less critical in their 
approach and journal reviewers and editors not as rigorous as 
they might otherwise be given the temptation to publish results 
(Catalogue of Bias Collaboration et al. 2017). In this review, 
we aspired to present a balanced and critical review of the cur-
rent evidence on the oral health effects of e-cigarettes and 
make recommendations for future research.
In Vitro Evidence
Toxicology studies have identified many components in 
e-cigarette aerosol (sometimes called vapor) that are hazardous 
to health, including nanoparticles, volatile organic compounds, 
carbonyls, heavy metals, and nicotine (Wang et al. 2019). 
Given that e-cigarette aerosol is inhaled, many studies have 
investigated effects on the respiratory system (Gotts et al. 
2019) or the in vitro effects on oral cells and tissues (Yang et al. 
2020). To date, at least 15 studies have investigated in vitro effects 
of e-cigarette exposure on 2-dimensional or 3-dimensional cell 
culture models involving normal, dysplastic, and cancerous 
oral keratinocytes, or gingival or periodontal ligament fibro-
blasts, including primary cells from human donors or estab-
lished cell lines (reviewed by Yang et al. 2020).
Early studies tended to expose cells directly to e-liquids 
(Willershausen et al. 2014; Sancilio et al. 2016; Welz et al. 
2016; Sancilio et al. 2017), giving an assessment of potential 
cellular effects. The studies reported cytotoxicity, which varied 
depending on the e-liquids used (Willershausen et al. 2014; 
Sancilio et al. 2016; Welz et al. 2016; Sancilio et al. 2017). 
Interestingly, none of these studies had a tobacco comparator. 
Unfortunately, this exposure method is not representative of 
the in vivo situation and often resulted in nonphysiological 
concentrations being studied. The use of cytotoxic levels of 
nicotine is an issue that has previously been identified with 
broader nicotine research (Holliday, Campbell, et al. 2019).
Later work used e-cigarette aerosol extracts, prepared from 
custom-made extraction machines, added to the cell culture 
medium (Ji et al. 2016; Sundar et al. 2016; Yu et al. 2016; 
Ganapathy et al. 2017; Alanazi et al. 2018; Ji et al. 2019; Sun 
et al. 2019). This is closer to in vivo conditions, but it is hard to 
fully assess due to varied media composition resulting from 
different puffing protocols and extract dilutions. These studies 
reported a range of effects, including cytotoxicity, reduced cell 
proliferation and migration, increased apoptosis and inflamma-
tory mediator production, and detection of oxidative damage 
such as protein carbonylation and DNA strand breaks (Fig. 1). 
Table. Summary of the Potential Merits and Disadvantages of E-Cigarettes.
Potential Merits Potential Disadvantages
Potential effectiveness as a smoking cessation aid—clinical trial  
evidence reports that e-cigarettes are twice as effective as  
conventional nicotine replacement therapy
Plausibly less health harms than conventional tobacco smoking
Effectiveness as cessation aid outside clinical settings (i.e., as consumer 
product) is unproven
As a quit aid, concerns over long-term use (users appear to use for longer 
than other products such as nicotine replacement therapy)
Behavioral characteristics replicate habit—hand-to-mouth action,  
vapor production—for current smokers
Several features valued by current tobacco smokers who would  
otherwise resist other cessation strategies: range of flavors and  
designs, nonmedicinal background and marketing, accessibility 
Unknown long-term health impacts
Regulatory approaches are varied around the world—rarely have 
e-cigarettes been regulated as strictly as medicinal products
Many features appeal to youth: range of flavors and designs, nonmedicinal 
background and marketing, accessibility
In some regions, uptake by youth has been rapid and widespread; nicotine 
dependence common among youth users
 Concerns over health harms such as brain development in adolescence
 Some marketing and advertising have substantial youth appeal
 Dual use of e-cigarettes and conventional cigarettes together is common 
and may cause harms similar to conventional smoking alone
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Some of these studies used tobacco smoke extract 
as a comparator and consistently reported this to be 
more damaging (Yu et al. 2016; Ganapathy et al. 
2017; Alanazi et al. 2018; Sun et al. 2019). Yu et al. 
(2016) found that tobacco smoke extract exposure 
was highly toxic, and they were only able to expose 
cells for 24 h without causing excessive cell death, 
whereas cells exposed to e-liquid extract survived for 
up to 8 wk, with new extract being added every 3 d.
More recent studies have exposed cells to e- 
cigarette aerosols directly, giving a more realistic 
exposure model. Rouabhia et al. (2017) reported 
altered cellular morphology, increased apoptosis/
necrosis, and increased lactate dehydrogenase activ-
ity but did not include a tobacco comparator. Finally, 
Iskandar et al. (2019) employed a state-of-the art 
exposure system with organotypic tissue models 
and air-liquid interface system to compare e- 
cigarette vapor with air and tobacco smoke controls. 
The e-cigarette aerosols exposure induced cellular 
and molecular changes but at lower levels than 
exposure to diluted (3% to 24%) tobacco smoke. 
There were some useful insights into specific com-
ponents of the e-liquid, with similar effects being 
seen between the carrier alone and when in combination with 
nicotine and flavorings.
It is important not to extrapolate directly from experimental 
results obtained in vitro to the clinical situation. For example, 
low-level changes in cell proliferation or apoptosis may not 
indicate an increased risk for oral cancer but could reflect the 
biological consequences of (naturally occurring) reestablish-
ment of cellular homeostasis. Furthermore, reported statisti-
cally significant differences are not necessarily relevant in a 
biological or medical context. Comparative assessment 
between e-cigarettes and tobacco smoke, as well as between 
different e-cigarettes, such as different flavors, may be the 
most useful, complementing clinical studies that are unable to 
evaluate large numbers of parameters. Long-term exposure 
studies are lacking and are likely to be problematic due to the 
requirement for aseptic cell culture conditions.
In summary, although e-cigarette aerosol has been shown to 
cause abnormalities in oral cells in vitro, the significance of 
these biological effects in vivo is currently unclear. In the 
future, carefully designed and interpreted in vitro studies using 
standardized protocols that more closely mimic conditions 
during human use will be essential to improve understanding 
of the true effects of e-cigarettes on oral cell biology.
Microbiological Evidence
Since most adult e-cigarette users are former tobacco smokers 
or dual users (those who continue to smoke), it is important to 
first understand the effects of smoking on the oral microbiome. 
Changes in the microbiome that are driven by smoking will 
potentially influence the baseline characteristics of e-cigarette 
users. However, the evidence regarding associations between 
tobacco smoking and the oral microbiome is evolving. For 
example, analysis of oral wash samples from 1,204 US adults 
identified depletion of Proteobacteria and enrichment for 
Firmicutes and Actinobacteria in smokers (Wu et al. 2016). By 
contrast, a smaller study that evaluated the microbiome at dif-
ferent sites in the mouth of 23 current smokers and 20 non-
smokers found little evidence for microbial shifts associated 
with smoking except at the buccal mucosa, where smokers had 
lower α-diversity (variation of microbes in a single sample) 
than nonsmokers (Yu et al. 2017). It is possible that changes 
are relatively subtle or highly variable and are not easily 
detected in small cohorts.
There is recent evidence that the use of e-cigarettes may 
influence the profile of the oral microbiome toward a state that 
is distinct from that present in nonsmokers or tobacco smokers. 
For example, shotgun sequencing of pooled subgingival plaque 
samples of periodontally healthy e-cigarette users (without a 
history of smoking), smokers, and controls identified nearly 300 
genes that were enriched in e-cigarette users, encoding compo-
nents of pathways such as arginine and alanine biosynthesis, 
metabolism of polyamines, 1-carbon compounds and (oligo)
saccharides, central carbon metabolism, fermentation, and cell 
cycle/cell division (Ganesan et al. 2020). Taxonomically, the 
microbiome in e-cigarette users had greater α-diversity and higher 
levels of several phyla and genera, including Actinobacteria, 
certain Firmicutes (including Selenomonas and Veillonella), 
Fusobacteria, Proteobacteria, and Saccharibacteria (Fig. 2). By 
contrast, Gram-negative obligate anaerobes were more strongly 
enriched in the subgingival biofilm of smokers. Similarly, the 
salivary microbiome appears to be distinct in e-cigarette users 
with no history of smoking compared with smokers or never-
smokers. Increased β-diversity (variation of microbial commu-
nities between samples) and higher levels of Actinomyces, 
Porphyromonas, and Veillonella were observed in e-cigarette 
Figure 1. The potential mechanisms of the impact of e-cigarettes on oral health 
as presented by in vitro and microbiological studies to date. E-cigarettes contain a 
variety of bioactive agents that induce potentially damaging effects on cells such as 
human oral keratinocytes and periodontal fibroblasts in vitro. There is evidence that 
the glycerol or polyethylene glycol (PEG) carrier may be responsible for increased 
biofilm volume and alterations to the composition of the microbiome. It is not known 
how these changes affect host cells. Conversely, the induction of inflammation by 
e-cigarettes and release of cytokines and antimicrobial peptides (AMPs) into saliva 
may affect the oral microbiome. VOCs, volatile organic compounds. Parts of this 
image are adapted from Servier Medical Art (https://smart.servier.com).
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users (Pushalkar et al. 2020). Conflictingly, an early pilot oral 
microbiome study of 10 e-cigarette users found no statistically 
significant differences from 10 nonsmokers (Stewart et al. 
2018). In 2 of the above studies, exhaled carbon monoxide levels 
were slightly higher in e-cigarette users than in the nonsmoker/
never-user control group (Stewart et al. 2018; Pushalkar et al. 
2020). Although differences were not statistically significant, it 
is possible that some of the e-cigarette cohort may also have 
smoked tobacco at some point prior to sampling. No data on 
carbon monoxide or salivary analyses were given by Ganesan 
et al. (2020). Overall, current evidence suggests that e-cigarette 
usage is associated with changes in the microbiome that are 
distinct from smoking. However, larger-scale studies in differ-
ent populations around the world with careful monitoring of 
smoking status are needed to clarify the associations between 
the oral microbiome and usage of e-cigarettes.
In vitro studies have shown that e-cigarette exposure has a 
relatively modest effect on the growth and survival of oral 
streptococci compared with cigarette smoke (Cuadra et al. 
2019). However, exposure to e-cigarette aerosol resulted in 
transcriptional changes in the related species Streptococcus 
pneumoniae without affecting virulence properties (Bagale et 
al. 2020). Similarly, transcriptional profiles of defined mixed-
species biofilms shifted in response to e-cigarette exposure 
(Ganesan et al. 2020). For example, pathways related to sialic 
acid metabolism were modulated in a variety of oral strepto-
cocci as well as Veillonella parvula, Actinomyces naeslundii, 
and Neisseria mucosa. Genes encoding functions related to 
biofilm matrix production and cell wall biosynthesis were also 
upregulated in biofilms. Biofilms exposed to e-cigarette aero-
sol were rich in matrix material and had greater surface area 
and volume than control biofilms. It is noteworthy 
that these effects appeared to be due to components 
of the e-cigarettes other than nicotine, most likely 
sugar alcohols such as glycerol or polyethylene gly-
col that are used as vehicles in e-cigarettes and can 
be a source of nutrients for microorganisms 
(Ganesan et al. 2020). It is also possible that e- 
cigarettes modulate the oral microbiome indirectly. 
Indeed, they have been shown to affect levels of 
antimicrobial proteins and cytokines in saliva 
(Cichońska et al. 2019; Ganesan et al. 2020). In 
vitro, e-cigarette exposure increased proinflamma-
tory cytokine production by premalignant and 
malignant cell lines, as well as accelerated infection 
by oral bacteria (Pushalkar et al. 2020). The evi-
dence to date, therefore, suggests that e-cigarette 
use has quantifiable effects on the oral microbi-
ome. However, the clinical implications of these 
effects and risk for oral disease have yet to be 
determined, and a significant limitation in this area 
is the lack of longitudinal studies. Furthermore, 
particularly within the context of periodontal dis-
eases, which are characterized by significant dys-
biosis of the subgingival microbiome, it may be 
challenging to reproducibly identify impacts of 
e-cigarette use.
Evidence from Clinical Studies
There are many challenges in conducting clinical research 
using e-cigarettes. Hence there are few studies to date, and 
most of these have significant limitations. Major barriers for 
clinical studies have included the regulatory environment and 
difficulties securing funding. For example, some research 
funders have not allowed their funds to cover smoking cessa-
tion studies using e-cigarettes or, if they allow them, they may 
not fund the provision of e-cigarette products and supplies to 
participants, meaning that researchers have to obtain additional 
funding to cover these costs.
A recent systematic review (Yang et al. 2020) identified 65 
clinical studies of the oral health impacts of e-cigarettes; most 
of these were observational and cross-sectional in design. An 
example of one of the earlier studies was a cross-sectional 
investigation of smokers, e-cigarette users, and nonusers (n = 
65) in which cytologic examination of oral mucosa scrapings 
was performed (Franco et al. 2016). These authors found that 
cell damage was significantly decreased in the e-cigarette 
group (as compared to current smokers), being similar to that 
seen in healthy controls (never smokers) and concluded that 
e-cigarettes were safe for oral cells.
Given the extensive evidence linking tobacco smoke with 
increased risk for periodontitis and peri-implant disease, it is 
natural that the impacts of e-cigarettes on these conditions 
have been among the most studied areas. Overall, evidence 
suggests that the risk of periodontal disease associated with 
e-cigarette use is less than that associated with tobacco 
Figure 2. Impact of e-cigarette use on the oral microbiome and metagenome. Based 
on data from Ganesan et al. (2020), e-cigarette users (who self-reported not smoking 
tobacco) had increased α-diversity and enrichment of species within several genera 
of bacteria in subgingival dental plaque compared with nonsmokers who had never 
used e-cigarettes. The inset table shows genera containing species that were also 
elevated in saliva of e-cigarette users compared with either nonsmokers or cigarette 
smokers in a separate study (Pushalkar et al. 2020). The use of e-cigarettes was 
associated with changes in 284 genes, encoding a variety of metabolic pathways and 
other functions. Several proinflammatory cytokines were elevated in e-cigarette users 
including interleukin (IL)-2 and IL-6, granulocyte-macrophage colony-stimulating factor 
(GM-CSF), tumor necrosis factor α (TNF-α), and interferon-γ (IFN-γ), whereas the 
anti-inflammatory cytokine IL-10 was decreased.
Electronic Cigarettes and Oral Health 5
smoking but more than that seen in nonsmokers. Whereas a 
spectrum of risk for periodontitis and peri-implantitis exists 
from nonsmokers to smokers, it is not possible from the current 
evidence base to confidently locate e-cigarette users within 
this. However, a number of studies have reported clinical 
improvements in those with preexisting periodontal disease 
when participants quit smoking and switched to using 
e-cigarettes, with and without periodontal therapies being pro-
vided (Javed et al. 2017; ALHarthi et al. 2019; BinShabaib et 
al. 2019). There are less data available for peri-implantitis, 
although cross-sectional studies have suggested effects are less 
harmful than those seen in smokers but more than those in non-
smokers (ArRejaie et al. 2019).
A pilot study (Wadia et al. 2016) that evaluated gingival 
bleeding in e-cigarette users is often cited in reviews (ArRejaie 
et al. 2019; Atuegwu et al. 2019) or public health documents 
(Stratton et al. 2018) as evidence of increased bleeding with 
e-cigarette use. The study, which followed 18 smokers who 
were asked to switch to an e-cigarette for 2 wk, observed an 
increase in bleeding on probing during the time of e-cigarette 
use. However, whether this was a direct result of switching to 
an e-cigarette or was simply the commonly observed clinical 
finding of a transient increase in gingival bleeding when a 
smoker quits (Nair et al. 2003) remains unknown.
Of the 8 randomized controlled trials (RCTs) identified by 
Yang et al (2020), 7 took place in nondental settings (collecting 
oral/throat health parameters as ancillary findings, usually self-
reported). A range of oral health outcomes were reported, with 
some studies finding more frequent complaints in e-cigarette 
users and others reporting fewer. One RCT was conducted in 
the dental setting and reported more detailed oral health mea-
sures (Holliday, Preshaw, et al. 2019). Although this RCT was 
pilot in design and hence not powered to provide definitive 
findings for smoking cessation or oral health outcomes, the 
authors reported descriptively that those in the e-cigarette 
group had a higher quit rate than those in the control group, and 
there were similar changes in oral health–related outcomes, 
including periodontal health parameters, oral dryness, and oral 
health quality of life between the 2 groups. Interestingly, there 
were 5 episodes of ulceration or soreness reported during the 
6-mo follow-up period, all occurring in the e-cigarette group. 
The pilot data from this study have informed the design of a 
definitive multicenter RCT, recently funded by the UK 
National Institute for Health Research, which plans to recruit 
1,460 smokers across 56 dental practices (HTA—NIHR129780 
2020).
In summary, the clinical evidence is limited and challenging 
to interpret but suggests that e-cigarettes are less harmful to 
oral health than tobacco cigarettes and might be an effective 
cessation aid in dental settings.
Epidemiological Evidence
Among prominent challenges in epidemiologically studying 
the oral health effects of e-cigarettes is that the most prevalent 
oral diseases are chronic conditions that develop over the life 
course, while e-cigarette use gained substantial popularity only 
within the past 5 to 10 y. In addition, most adult e-cigarette 
users are current or former cigarette smokers, making it diffi-
cult to separate any e-cigarette effects from oral health prob-
lems caused by prior or current conventional smoking. 
Furthermore, given that periodontal disease risk increases with 
age, the much higher e-cigarette use prevalence among younger 
individuals not only confounds associations but also might 
obscure health effects not manifest until later life. Currently, 
most epidemiologic studies of e-cigarettes and oral health rely 
on cross-sectional designs and self-reported health measures, 
which limits evidence quality. It may require decades to esti-
mate precisely the population-level impact of e-cigarettes on 
oral health, but emerging associations suggest potential for 
harm.
Numerous case reports demonstrate the presence of oral 
mucosal, tongue, or ulcerative lesions in patients who use 
e-cigarettes, as recently reviewed (Yang et al. 2020). The popu-
lation prevalence of such lesions and whether directly caused 
by e-cigarette use cannot be inferred from case reports. 
However, a number of cases of maxillofacial trauma are read-
ily attributable to explosive e-cigarette device failures, includ-
ing intraoral burns and alveolar fractures. While these traumatic 
injuries are notable for dental practice, such explosions are 
presumably avoidable with quality manufacturing standards.
A number of studies not explicitly designed to assess oral 
health have identified dry mouth and mouth or throat irritation 
as common symptoms among e-cigarette users. In a systematic 
review of 11 studies that assessed e-cigarettes as potential 
smoking cessation aids, cough or mouth/throat irritation was 
the most commonly reported group of adverse events, occur-
ring in up to 39% of participants (Liu et al. 2018). This cor-
roborates a US national telephone survey in which cough 
(40%) and dry or irritated mouth or throat (31%) were the most 
common of 6 recorded symptoms among adult e-cigarette 
ever-users (King et al. 2019).
In nationally representative cross-sectional studies, associa-
tions between e-cigarette use and worse oral health have been 
reported, including after confounding adjustment. Among chil-
dren in South Korea, mouth pain and broken or cracked teeth 
were associated with e-cigarette use (Cho 2017). In the United 
States, parent report of “dental problems” was more common 
among children who used both e-cigarettes and conventional 
cigarettes versus tobacco nonusers (Akinkugbe 2019). Among 
US adults, daily e-cigarette users were slightly more likely to 
report ever having a tooth removed for gum disease or decay 
than were never-users (56% vs. 51%) (Huilgol et al. 2019). 
Similarly, ever being diagnosed or treated for gingival disease 
was higher among e-cigarette users than tobacco never-users 
(Vora and Chaffee 2019). In South Korea, the odds of 
examiner-measured periodontal disease were approximately 
double for both e-cigarette users and conventional cigarette 
smokers versus nonusers (Jeong et al. 2020).
There are few sources of longitudinal evidence, and 
epidemiologic data from outside the United States and South 
Korea are currently lacking. In 1 US study, adults who used 
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e-cigarettes in 3 consecutive annual survey waves had higher 
odds at the third wave of self-reported gingival disease and 
bone loss around teeth (Atuegwu et al. 2019).
Synthesis of the Evidence
Throughout the 4 sections of this review, we have explored the 
many challenges of studying the oral health consequences of 
e-cigarette use and limitations of the current evidence base. 
While a number of studies suggest that oral health harms are 
plausible, it remains difficult to quantify the potential risks to 
patients.
A common challenge is the heterogeneity of the product cat-
egory, given that there are hundreds of different e-cigarette 
devices, thousands of e-liquid and flavor formulations, and a 
constantly changing market. Hence, generalizing the findings of 
a study on a single product to the whole e-cigarette universe can 
be challenging. User choice is also another particularly unique 
aspect of e-cigarette interventions and does not easily fit within 
the tightly controlled designs of clinical trials. Accordingly, we 
consider that clinical trials (including RCTs) are best designed to 
be at the pragmatic end of the explanatory-pragmatic spectrum 
(Loudon et al. 2015). For example, this might involve providing 
an e-cigarette starter kit and advice, then allowing participants to 
source their own supplies thereafter (and accepting that they 
may switch flavors or nicotine concentrations over time). 
Findings from clinical trials are best presented and interpreted in 
this broad sector-wide context. In vitro studies will also play a 
useful role in assessing the relative effects between the different 
parameters (nicotine concentrations, flavors, carrier solutions, 
device settings, and puffing patterns), which would be impracti-
cal to evaluate in clinical studies.
An important consideration when appraising studies in this 
field relates to perspective (influenced by participant groups) 
and the comparisons that are made. There are 2 very different 
populations that are typically studied: 1) never-smoker e-ciga-
rette users with no preexisting oral health conditions, perhaps 
representing a young person who takes up vaping, having 
never smoked tobacco previously; or 2) tobacco smokers who 
are using an e-cigarette to quit or for other reasons and who 
will often have preexisting oral disease such as periodontitis. 
This latter group may also be “dual users” in that they may be 
using both tobacco cigarettes and an e-cigarette at the same 
time. Most of the evidence suggesting harm from e-cigarettes 
comes from studies on the first group (healthy individuals), 
highlighting the importance of public health efforts to reduce 
use in nonsmokers. For the latter group (smokers with existing 
oral diseases), observing and measuring the oral health impacts 
of e-cigarettes is complex; any minor changes can be masked 
by the preexisting disease status and concurrent changes in 
tobacco use (e.g., increased e-cigarette use and decreased 
tobacco use). Hence, studies should be interpreted cautiously, 
and it is important to not overgeneralize findings from specific 
populations.
It is clear from the existing evidence that tobacco smoking 
has major negative impacts on oral health (US Surgeon General 
2014). Dental professionals are potentially in a powerful 
position to provide smoking cessation advice and support, and 
this is known to be well received by patients (Holliday et al. 
2020). There are a range of proven behavioral and pharmaco-
logical interventions available. E-cigarettes may become a use-
ful addition to this armamentarium, pending further study. The 
evidence base suggests that e-cigarette use has the potential to 
cause oral health consequences, particularly in those with no 
existing oral disease, and efforts in preventing use in nonsmok-
ers are therefore critical. However, for smokers with existing 
oral diseases, the major benefits of quitting tobacco smoking 
are likely to outweigh any negative impacts from e-cigarette 
use, particularly over the short term. Hence, if a smoker is keen 
to use an e-cigarette as part of a quit attempt, we consider 
(according to currently available evidence) that they should not 
be discouraged from doing so based on oral health concerns. 
However, we further consider that such use of e-cigarettes 
should be as part of a structured quit attempt and participating 
individuals offered additional cessation support, such as pro-
fessional counseling and pharmacotherapy as appropriate to 
the situation.
Along with the existing challenges we have discussed, there 
are a range of future hurdles for researchers in this field, not 
least being the fact that new products are continually emerging 
or gaining popularity, such as heated tobacco products and dis-
solvable tobacco and nicotine pouches. Future research should 
focus on these products as they emerge.
Conclusions
Studying the oral health consequences of e-cigarette use is 
challenging given the changing nature of the products and dif-
ficulties of identifying potential e-cigarette effects in patients 
with a past or current history of combustible tobacco use. 
While the evidence base is limited, it does suggest that there 
are potential oral health harms associated with e-cigarette use. 
For those using e-cigarettes as a tobacco quit aid, the evidence 
of oral health impacts is uncertain and complicated by the sub-
stantial oral health changes that occur when users quit tobacco 
smoking. There is a clear need for further well-conducted stud-
ies in this field. Those areas that have the strongest potential to 
benefit patients are understanding the oral health consequences 
in nonsmokers who initiate e-cigarette use, establishing the 
effectiveness of e-cigarettes as a tobacco quit aid (especially 
within the dental setting), and understanding any impacts on 
periodontal health in smokers who switch to e-cigarettes.
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